EP
Elemer Piros LUCID CAPITAL MARKETS Latest Price Targets & Analyst Ratings
# | Stock | Price | Price Target |
Upside Downside | Rating | Date | |
---|---|---|---|---|---|---|---|
1 |
1
ATAI Life Sciences
ATAI
$1.03B
| $4.79 | $15 |
213%
upside
| Buy | 2 years ago |
|
2 |
2
MindMed
MNMD
$707M
| $9.29 | $21 |
126%
upside
| Buy | 2 years ago |
|
3 |
CMPS
3
Compass Pathways
CMPS
$456M
| $4.75 | $38 |
700%
upside
| Buy | 2 years ago |
|
4 |
4
GH Research
GHRS
$862M
| $13.89 | $33 |
138%
upside
| Buy | 2 years ago |
|
5 |
5
GH Research
GHRS
$862M
| $13.89 | $66 |
375%
upside
| Buy | 3 years ago |
|
6 |
6
MindMed
MNMD
$707M
| $9.29 | $105 |
1,030%
upside
| Buy | 3 years ago |
|
7 |
7
Apellis Pharmaceuticals
APLS
$3.58B
| $28.34 | $40 |
41%
upside
| Sell | 3 years ago |
|
8 |
8
ATAI Life Sciences
ATAI
$1.03B
| $4.79 | $32 |
568%
upside
| Buy | 3 years ago |
|
9 |
9
DiaMedica Therapeutics
DMAC
$272M
| $5.26 | $32 |
508%
upside
| Buy | 4 years ago |
|
10 |
CMPS
10
Compass Pathways
CMPS
$456M
| $4.75 | $88 |
1,753%
upside
| Buy | 4 years ago |
|
11 |
11
Arcturus Therapeutics
ARCT
$477M
| $17.57 | $77 |
338%
upside
| Sell | 4 years ago |
|